SEC 13F Intelligence

Groesbeck Investment Management Corp /Nj/ / VRTX

Groesbeck Investment Management Corp /Nj/’s Vertex Pharmaceuticals Inc Position

Does Groesbeck Investment Management Corp /Nj/ own Vertex Pharmaceuticals Inc (VRTX)? Yes1.5K shares worth $656,000 (+1.28% of its 13F portfolio) as of Q1 2026, up from 1.4K shares the prior filed quarter.

Position Value
$656,000
Q1 2026
Shares
1.5K
% of Portfolio
+1.28%
Quarters Held
23
currently held

Position History VRTX

Reported value by quarter
Q2 ’20: $450,000Q2 ’20Q3 ’20: $425,000Q4 ’20: $369,000Q1 ’21: $336,000Q1 ’21Q2 ’21: $234,000Q3 ’21: $202,000Q4 ’21: $244,000Q4 ’21Q1 ’22: $290,000Q2 ’22: $314,000Q3 ’22: $314,000Q3 ’22Q4 ’22: $356,000Q1 ’23: $388,000Q2 ’23: $434,000Q2 ’23Q3 ’23: $512,000Q4 ’23: $721,000Q1 ’24: $741,000Q1 ’24Q2 ’24: $841,000Q3 ’24: $823,000Q4 ’24: $753,000Q4 ’24Q1 ’25: $906,000Q3 ’25: $532,000Q4 ’25: $616,000Q4 ’25Q1 ’26: $656,000filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.5K$656,000+1.28%
Q4 20251.4K$616,000+1.16%
Q3 20251.4K$532,000+1.04%
Q1 20251.9K$906,000+1.27%
Q4 20241.9K$753,000+0.98%
Q3 20241.8K$823,000+1.21%
Q2 20241.8K$841,000+1.16%
Q1 20241.8K$741,000+0.79%
Q4 20231.8K$721,000+1.00%
Q3 20231.5K$512,000+0.78%
Q2 20231.2K$434,000+0.66%
Q1 20231.2K$388,000+0.58%
Q4 20221.2K$356,000+0.60%
Q3 20221.1K$314,000+0.52%
Q2 20221.1K$314,000+0.52%
Q1 20221.1K$290,000+0.32%
Q4 20211.1K$244,000+0.31%
Q3 20211.1K$202,000+0.23%
Q2 20211.2K$234,000+0.30%
Q1 20211.6K$336,000+0.48%
Q4 20201.6K$369,000+0.60%
Q3 20201.6K$425,000+0.80%
Q2 20201.6K$450,000+0.89%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Groesbeck Investment Management Corp /Nj/’s full portfolio or all institutional holders of VRTX.